198 related articles for article (PubMed ID: 33504179)
1. Telomerase as a Therapeutic Target in Cardiovascular Disease.
Hoffmann J; Richardson G; Haendeler J; Altschmied J; Andrés V; Spyridopoulos I
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1047-1061. PubMed ID: 33504179
[TBL] [Abstract][Full Text] [Related]
2. Oxidative damage impact on aging and age-related diseases: drug targeting of telomere attrition and dynamic telomerase activity flirting with imidazole-containing dipeptides.
Babizhayev MA; Vishnyakova KS; Yegorov YE
Recent Pat Drug Deliv Formul; 2014; 8(3):163-92. PubMed ID: 24894799
[TBL] [Abstract][Full Text] [Related]
3. Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.
Ait-Aissa K; Ebben JD; Kadlec AO; Beyer AM
Pharmacol Res; 2016 Sep; 111():422-433. PubMed ID: 27394166
[TBL] [Abstract][Full Text] [Related]
4. Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells.
Richardson GD; Sage A; Bennaceur K; Al Zhrany N; Coelho-Lima J; Dookun E; Draganova L; Saretzki G; Breault DT; Mallat Z; Spyridopoulos I
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1283-1296. PubMed ID: 29599138
[TBL] [Abstract][Full Text] [Related]
5. Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population.
Dai J; Cai H; Zhuang Y; Wu Y; Min H; Li J; Shi Y; Gao Q; Yi L
Respirology; 2015 Jan; 20(1):122-8. PubMed ID: 25346280
[TBL] [Abstract][Full Text] [Related]
6. Regulation and Effect of Telomerase and Telomeric Length in Stem Cells.
Celtikci B; Erkmen GK; Dikmen ZG
Curr Stem Cell Res Ther; 2021; 16(7):809-823. PubMed ID: 32321410
[TBL] [Abstract][Full Text] [Related]
7. [CLINICAL CASE: THE SIDE EFFECTS OF STATINS].
Kukes V; Chebyshev N; Pavlova L; Berechikidze I; Degtyarevskaya T; Badriddinova L
Georgian Med News; 2020 Feb; (299):75-78. PubMed ID: 32242849
[TBL] [Abstract][Full Text] [Related]
8. Phenotypes in mTERT⁺/⁻ and mTERT⁻/⁻ mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase.
Strong MA; Vidal-Cardenas SL; Karim B; Yu H; Guo N; Greider CW
Mol Cell Biol; 2011 Jun; 31(12):2369-79. PubMed ID: 21464209
[TBL] [Abstract][Full Text] [Related]
9. Telomere homeostasis in trophoblasts and in cord blood cells from pregnancies complicated with preeclampsia.
Sukenik-Halevy R; Amiel A; Kidron D; Liberman M; Ganor-Paz Y; Biron-Shental T
Am J Obstet Gynecol; 2016 Feb; 214(2):283.e1-283.e7. PubMed ID: 26321036
[TBL] [Abstract][Full Text] [Related]
10. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
[TBL] [Abstract][Full Text] [Related]
11. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
12. Novel neuroendocrine and metabolic mechanism provides the patented platform for important rejuvenation therapies: targeted therapy of telomere attrition and lifestyle changes of telomerase activity with the timing of neuron-specific imidazole-containing dipeptide-dominant pharmaconutrition provision.
Babizhayev MA; Kasus-Jacobi A; Vishnyakova KS; Yegorov YE
Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):153-79. PubMed ID: 24910283
[TBL] [Abstract][Full Text] [Related]
13. Role of the ESCRT Complexes in Telomere Biology.
Dieckmann AK; Babin V; Harari Y; Eils R; König R; Luke B; Kupiec M
mBio; 2016 Nov; 7(6):. PubMed ID: 27834202
[TBL] [Abstract][Full Text] [Related]
14. Telomere shortening and telomerase activity in ischaemic cardiomyopathy patients - Potential markers of ventricular arrhythmia.
Sawhney V; Campbell NG; Brouilette SW; Coppen SR; Harbo M; Baker V; Ikebe C; Shintani Y; Hunter RJ; Dhinoja M; Johnston A; Earley MJ; Sporton S; Bendix L; Suzuki K; Schilling RJ
Int J Cardiol; 2016 Mar; 207():157-63. PubMed ID: 26803233
[TBL] [Abstract][Full Text] [Related]
15. Cell aging in relation to stress arousal and cardiovascular disease risk factors.
Epel ES; Lin J; Wilhelm FH; Wolkowitz OM; Cawthon R; Adler NE; Dolbier C; Mendes WB; Blackburn EH
Psychoneuroendocrinology; 2006 Apr; 31(3):277-87. PubMed ID: 16298085
[TBL] [Abstract][Full Text] [Related]
16. Telomere-associated aging disorders.
Opresko PL; Shay JW
Ageing Res Rev; 2017 Jan; 33():52-66. PubMed ID: 27215853
[TBL] [Abstract][Full Text] [Related]
17. Hostility and cellular aging in men from the Whitehall II cohort.
Brydon L; Lin J; Butcher L; Hamer M; Erusalimsky JD; Blackburn EH; Steptoe A
Biol Psychiatry; 2012 May; 71(9):767-73. PubMed ID: 21974787
[TBL] [Abstract][Full Text] [Related]
18. Telomeres and telomerase in risk assessment of cardiovascular diseases.
Boniewska-Bernacka E; Pańczyszyn A; Klinger M
Exp Cell Res; 2020 Dec; 397(2):112361. PubMed ID: 33171154
[TBL] [Abstract][Full Text] [Related]
19. Questioning causal involvement of telomeres in aging.
Simons MJ
Ageing Res Rev; 2015 Nov; 24(Pt B):191-6. PubMed ID: 26304838
[TBL] [Abstract][Full Text] [Related]
20. Telomerase redux: ready for prime time?
Larrick JW; Mendelsohn AR
Rejuvenation Res; 2015 Apr; 18(2):185-7. PubMed ID: 25790341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
